(-)-epigallocatechin 3-gallate multiple interactions ISO SSBP2 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SSBP2 mRNA CTD PMID:22079256 1,2-dimethylhydrazine decreases expression ISO Ssbp2 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of SSBP2 mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions ISO Ssbp2 (Mus musculus) 6480464 Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in decreased expression of SSBP2 mRNA] CTD PMID:22206623 17alpha-ethynylestradiol multiple interactions ISO Ssbp2 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SSBP2 mRNA CTD PMID:17942748 17beta-estradiol multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of SSBP2 mRNA CTD PMID:26496021 17beta-estradiol multiple interactions ISO SSBP2 (Homo sapiens) 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of SSBP2 mRNA CTD PMID:30165855 17beta-estradiol decreases expression ISO SSBP2 (Homo sapiens) 6480464 Estradiol results in decreased expression of SSBP2 mRNA CTD PMID:26865669 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO SSBP2 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in increased expression of SSBP2 mRNA CTD PMID:20106945 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Ssbp2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of SSBP2 mRNA CTD PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Ssbp2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of SSBP2 mRNA CTD PMID:19933214 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Ssbp2 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SSBP2 mRNA and [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of SSBP2 mRNA CTD PMID:17942748 and PMID:25975270 2-methylcholine affects expression ISO SSBP2 (Homo sapiens) 6480464 beta-methylcholine affects the expression of SSBP2 mRNA CTD PMID:21179406 3,4-methylenedioxymethamphetamine increases expression ISO Ssbp2 (Mus musculus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of SSBP2 mRNA CTD PMID:20188158 and PMID:26251327 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO SSBP2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of SSBP2 mRNA CTD PMID:28628672 4,4'-diaminodiphenylmethane increases expression ISO Ssbp2 (Mus musculus) 6480464 4 and 4'-diaminodiphenylmethane results in increased expression of SSBP2 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of SSBP2 mRNA CTD PMID:36041667 5-aza-2'-deoxycytidine increases expression ISO SSBP2 (Homo sapiens) 6480464 Decitabine results in increased expression of SSBP2 mRNA CTD PMID:19194470 5-aza-2'-deoxycytidine multiple interactions ISO SSBP2 (Homo sapiens) 6480464 [Decitabine affects the methylation of SSBP2 promoter] which affects the expression of SSBP2 mRNA and [Decitabine affects the methylation of SSBP2 promoter] which affects the expression of SSBP2 protein CTD PMID:18559593 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of SSBP2 mRNA CTD PMID:24780913 and PMID:36843608 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of SSBP2 mRNA CTD PMID:30047161 acrylamide decreases expression ISO SSBP2 (Homo sapiens) 6480464 Acrylamide results in decreased expression of SSBP2 mRNA CTD PMID:32763439 aflatoxin B1 decreases expression ISO Ssbp2 (Mus musculus) 6480464 Aflatoxin B1 results in decreased expression of SSBP2 mRNA CTD PMID:19770486 aflatoxin B1 decreases methylation ISO SSBP2 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased methylation of SSBP2 intron CTD PMID:30157460 Aflatoxin B2 alpha decreases methylation ISO SSBP2 (Homo sapiens) 6480464 aflatoxin B2 results in decreased methylation of SSBP2 intron CTD PMID:30157460 all-trans-retinoic acid decreases expression ISO SSBP2 (Homo sapiens) 6480464 Tretinoin results in decreased expression of SSBP2 mRNA CTD PMID:21934132 and PMID:33167477 amitrole decreases expression EXP 6480464 Amitrole results in decreased expression of SSBP2 mRNA CTD PMID:30047161 antirheumatic drug increases expression ISO SSBP2 (Homo sapiens) 6480464 Antirheumatic Agents results in increased expression of SSBP2 mRNA CTD PMID:24449571 aristolochic acid A decreases expression ISO SSBP2 (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of SSBP2 mRNA CTD PMID:33212167 arsenous acid decreases expression ISO SSBP2 (Homo sapiens) 6480464 Arsenic Trioxide results in decreased expression of SSBP2 mRNA CTD PMID:26705709 atrazine increases expression ISO SSBP2 (Homo sapiens) 6480464 Atrazine results in increased expression of SSBP2 mRNA CTD PMID:22378314 atrazine affects methylation EXP 6480464 Atrazine affects the methylation of SSBP2 gene CTD PMID:35440735 benzo[a]pyrene decreases expression ISO Ssbp2 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of SSBP2 mRNA CTD PMID:19770486 benzo[a]pyrene increases methylation ISO Ssbp2 (Mus musculus) 6480464 Benzo(a)pyrene results in increased methylation of SSBP2 intron CTD PMID:27901495 benzo[a]pyrene increases expression ISO Ssbp2 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of SSBP2 mRNA CTD PMID:22228805 benzo[a]pyrene diol epoxide I decreases expression ISO SSBP2 (Homo sapiens) 6480464 7 more ... CTD PMID:19150397 benzo[a]pyrene diol epoxide I affects expression ISO SSBP2 (Homo sapiens) 6480464 7 more ... CTD PMID:20382639 benzo[e]pyrene affects methylation ISO SSBP2 (Homo sapiens) 6480464 benzo(e)pyrene affects the methylation of SSBP2 intron CTD PMID:30157460 bisphenol A increases expression ISO Ssbp2 (Mus musculus) 6480464 bisphenol A results in increased expression of SSBP2 mRNA CTD PMID:26063408 bisphenol A decreases expression ISO SSBP2 (Homo sapiens) 6480464 bisphenol A results in decreased expression of SSBP2 mRNA CTD PMID:28711546 bisphenol A multiple interactions ISO SSBP2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of SSBP2 mRNA CTD PMID:28628672 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SSBP2 mRNA CTD PMID:25181051 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of SSBP2 mRNA and [bisphenol A co-treated with Estradiol] results in decreased expression of SSBP2 mRNA CTD PMID:26496021 and PMID:36041667 bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of SSBP2 mRNA CTD PMID:36041667 cadmium atom decreases expression ISO SSBP2 (Homo sapiens) 6480464 Cadmium results in decreased expression of SSBP2 mRNA CTD PMID:23369406 carbamazepine affects expression ISO SSBP2 (Homo sapiens) 6480464 Carbamazepine affects the expression of SSBP2 mRNA CTD PMID:25979313 CGP 52608 multiple interactions ISO SSBP2 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to SSBP2 gene] CTD PMID:28238834 chlorpyrifos increases expression ISO Ssbp2 (Mus musculus) 6480464 Chlorpyrifos results in increased expression of SSBP2 mRNA CTD PMID:37019170 chromium(6+) decreases expression ISO SSBP2 (Homo sapiens) 6480464 chromium hexavalent ion results in decreased expression of SSBP2 mRNA CTD PMID:30690063 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of SSBP2 mRNA CTD PMID:22023808 cisplatin multiple interactions ISO SSBP2 (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of SSBP2 mRNA CTD PMID:27392435 clomiphene increases expression ISO SSBP2 (Homo sapiens) 6480464 Clomiphene results in increased expression of SSBP2 mRNA CTD PMID:26865669 coumestrol multiple interactions ISO SSBP2 (Homo sapiens) 6480464 [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SSBP2 mRNA CTD PMID:19167446 decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of SSBP2 mRNA CTD PMID:23640034 dexamethasone multiple interactions ISO SSBP2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of SSBP2 mRNA CTD PMID:28628672 diarsenic trioxide decreases expression ISO SSBP2 (Homo sapiens) 6480464 Arsenic Trioxide results in decreased expression of SSBP2 mRNA CTD PMID:26705709 diethylstilbestrol decreases expression ISO SSBP2 (Homo sapiens) 6480464 Diethylstilbestrol results in decreased expression of SSBP2 mRNA CTD PMID:26865669 dorsomorphin multiple interactions ISO SSBP2 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO SSBP2 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of SSBP2 mRNA CTD PMID:29803840 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of SSBP2 mRNA CTD PMID:29391264 Enterolactone multiple interactions ISO SSBP2 (Homo sapiens) 6480464 [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SSBP2 mRNA CTD PMID:19167446 entinostat decreases expression ISO SSBP2 (Homo sapiens) 6480464 entinostat results in decreased expression of SSBP2 mRNA CTD PMID:26272509 entinostat multiple interactions ISO SSBP2 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SSBP2 mRNA CTD PMID:27188386 epoxiconazole decreases expression ISO Ssbp2 (Mus musculus) 6480464 epoxiconazole results in decreased expression of SSBP2 mRNA CTD PMID:35436446 ethanol affects splicing ISO Ssbp2 (Mus musculus) 6480464 Ethanol affects the splicing of SSBP2 mRNA CTD PMID:30319688 fipronil decreases expression EXP 6480464 fipronil results in decreased expression of SSBP2 mRNA CTD PMID:34044035 folic acid multiple interactions ISO Ssbp2 (Mus musculus) 6480464 Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in decreased expression of SSBP2 mRNA] CTD PMID:22206623 formaldehyde decreases expression ISO SSBP2 (Homo sapiens) 6480464 Formaldehyde results in decreased expression of SSBP2 mRNA CTD PMID:23649840 fulvestrant increases expression ISO SSBP2 (Homo sapiens) 6480464 fulvestrant results in increased expression of SSBP2 mRNA CTD PMID:26865669 genistein decreases expression ISO SSBP2 (Homo sapiens) 6480464 Genistein results in decreased expression of SSBP2 mRNA CTD PMID:26865669 hexestrol decreases expression ISO SSBP2 (Homo sapiens) 6480464 Hexestrol results in decreased expression of SSBP2 mRNA CTD PMID:26865669 indometacin multiple interactions ISO SSBP2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of SSBP2 mRNA CTD PMID:28628672 mestranol decreases expression ISO SSBP2 (Homo sapiens) 6480464 Mestranol results in decreased expression of SSBP2 mRNA CTD PMID:26865669 methapyrilene affects methylation ISO SSBP2 (Homo sapiens) 6480464 Methapyrilene affects the methylation of SSBP2 intron CTD PMID:30157460 methimazole decreases expression EXP 6480464 Methimazole results in decreased expression of SSBP2 mRNA CTD PMID:30047161 methoxychlor affects methylation EXP 6480464 Methoxychlor affects the methylation of SSBP2 gene CTD PMID:35440735 methylmercury chloride decreases expression ISO SSBP2 (Homo sapiens) 6480464 methylmercuric chloride results in decreased expression of SSBP2 mRNA CTD PMID:28001369 methylseleninic acid increases expression ISO SSBP2 (Homo sapiens) 6480464 methylselenic acid results in increased expression of SSBP2 mRNA CTD PMID:18548127 N-nitrosodiethylamine decreases expression ISO SSBP2 (Homo sapiens) 6480464 Diethylnitrosamine results in decreased expression of SSBP2 mRNA CTD PMID:21527772 nickel atom decreases expression ISO SSBP2 (Homo sapiens) 6480464 Nickel results in decreased expression of SSBP2 mRNA CTD PMID:24768652 and PMID:25583101 nickel sulfate decreases expression ISO SSBP2 (Homo sapiens) 6480464 nickel sulfate results in decreased expression of SSBP2 mRNA CTD PMID:22714537 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of SSBP2 mRNA CTD PMID:25729387 panobinostat multiple interactions ISO SSBP2 (Homo sapiens) 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SSBP2 mRNA CTD PMID:27188386 panobinostat decreases expression ISO SSBP2 (Homo sapiens) 6480464 panobinostat results in decreased expression of SSBP2 mRNA CTD PMID:26272509 perfluorohexanesulfonic acid increases expression ISO Ssbp2 (Mus musculus) 6480464 perfluorohexanesulfonic acid results in increased expression of SSBP2 mRNA CTD PMID:37995155 phenylmercury acetate decreases expression ISO SSBP2 (Homo sapiens) 6480464 Phenylmercuric Acetate results in decreased expression of SSBP2 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO SSBP2 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SSBP2 mRNA CTD PMID:27188386 potassium chromate multiple interactions ISO SSBP2 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SSBP2 mRNA CTD PMID:22079256 potassium chromate decreases expression ISO SSBP2 (Homo sapiens) 6480464 potassium chromate(VI) results in decreased expression of SSBP2 mRNA CTD PMID:22079256 and PMID:22714537 raloxifene increases expression ISO SSBP2 (Homo sapiens) 6480464 Raloxifene Hydrochloride results in increased expression of SSBP2 mRNA CTD PMID:26865669 SB 431542 multiple interactions ISO SSBP2 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide decreases expression ISO SSBP2 (Homo sapiens) 6480464 Silicon Dioxide analog results in decreased expression of SSBP2 mRNA and Silicon Dioxide results in decreased expression of SSBP2 mRNA CTD PMID:25351596 and PMID:25895662 silver atom decreases expression ISO Ssbp2 (Mus musculus) 6480464 Silver results in decreased expression of SSBP2 mRNA CTD PMID:27131904 silver(0) decreases expression ISO Ssbp2 (Mus musculus) 6480464 Silver results in decreased expression of SSBP2 mRNA CTD PMID:27131904 sodium arsenite decreases expression ISO SSBP2 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of SSBP2 mRNA CTD PMID:34032870 sulfadimethoxine decreases expression EXP 6480464 Sulfadimethoxine results in decreased expression of SSBP2 mRNA CTD PMID:30047161 sulforaphane decreases expression ISO SSBP2 (Homo sapiens) 6480464 sulforaphane results in decreased expression of SSBP2 mRNA CTD PMID:31838189 sunitinib increases expression ISO SSBP2 (Homo sapiens) 6480464 Sunitinib results in increased expression of SSBP2 mRNA CTD PMID:31533062 testosterone decreases expression ISO SSBP2 (Homo sapiens) 6480464 Testosterone results in decreased expression of SSBP2 mRNA CTD PMID:33359661 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of SSBP2 mRNA CTD PMID:34492290 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of SSBP2 mRNA CTD PMID:25729387 trichostatin A decreases expression ISO SSBP2 (Homo sapiens) 6480464 trichostatin A results in decreased expression of SSBP2 mRNA CTD PMID:26272509 trichostatin A multiple interactions ISO SSBP2 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SSBP2 mRNA CTD PMID:27188386 trimellitic anhydride decreases expression ISO Ssbp2 (Mus musculus) 6480464 trimellitic anhydride results in decreased expression of SSBP2 mRNA CTD PMID:19042947 triptonide increases expression ISO Ssbp2 (Mus musculus) 6480464 triptonide results in increased expression of SSBP2 mRNA CTD PMID:33045310 tungsten increases expression ISO Ssbp2 (Mus musculus) 6480464 Tungsten results in increased expression of SSBP2 mRNA CTD PMID:30912803 valproic acid increases expression ISO SSBP2 (Homo sapiens) 6480464 Valproic Acid results in increased expression of SSBP2 mRNA CTD PMID:29154799 valproic acid decreases expression ISO SSBP2 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of SSBP2 mRNA CTD PMID:23179753 and PMID:28001369
